DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Thrombosis

Drug Information

Target Indication

Thrombosis

Clinical Trial

Last updated: 1/6/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

DSKYF

Daiichi Sankyo

Related Pipeline

Advanced Cancer

Leukemia

Venous Thromboembolism (VTE)

Head and Neck Cancer

Neoplasm, Gastrointestinal

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts